Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Allergy ; 72(10): 1521-1531, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28273344

RESUMEN

BACKGROUND: Interleukin (IL)-33 is implicated in the pathophysiology of asthma and allergic diseases. However, our knowledge is limited regarding how IL-33 release is controlled. The transcription factor nuclear factor-erythroid-2-related factor 2 (Nrf2) plays a key role in antioxidant response regulation. OBJECTIVE: The goal of this project was to investigate the role of cellular oxidative stress in controlling IL-33 release in airway epithelium. METHODS: Complementary approaches were used that included human bronchial epithelial cells and mouse models of airway type-2 immunity that were exposed to fungus Alternaria extract. The clinically available Nrf2 activator 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid methyl ester (CDDO-Me) was used to evaluate the role of Nrf2-induced antioxidant molecules. RESULTS: Human bronchial epithelial cells produced reactive oxygen species (ROS) when they were exposed to Alternaria extract. ROS scavengers, such as glutathione (GSH) and N-acetyl cysteine, prevented extracellular secretion of ATP and increases in intracellular calcium concentrations that precede IL-33 release. Administration of CDDO-Me to mice enhanced expression of a number of antioxidant molecules in the lungs and elevated lung levels of endogenous GSH. Importantly, CDDO-Me treatment reduced allergen-induced ATP secretion and IL-33 release by airway epithelial cells in vitro and protected mice from IL-33 release and asthma-like pathological changes in the lungs. CONCLUSIONS: The balance between oxidative stress and antioxidant responses plays a key role in controlling IL-33 release in airway epithelium. The therapeutic potential of Nrf2 activators needs to be considered for asthma and allergic airway diseases.


Asunto(s)
Interleucina-33/metabolismo , Estrés Oxidativo , Adenosina Trifosfato/metabolismo , Alérgenos/inmunología , Animales , Antioxidantes/metabolismo , Calcio/metabolismo , Células Epiteliales/metabolismo , Femenino , Humanos , Pulmón/efectos de los fármacos , Pulmón/inmunología , Pulmón/metabolismo , Ratones , Ratones Noqueados , Factor 2 Relacionado con NF-E2/metabolismo , Ácido Oleanólico/análogos & derivados , Ácido Oleanólico/farmacología , Especies Reactivas de Oxígeno/metabolismo , Mucosa Respiratoria/inmunología , Mucosa Respiratoria/metabolismo
2.
Am J Physiol ; 253(2 Pt 1): C177-92, 1987 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-3303961

RESUMEN

This review summarizes our present understanding of Na-K-Cl cotransport and its physiological role in absorption and secretion of electrolytes and water in epithelial tissues. In the past several years an extensive literature about this cotransporter has developed due to its widespread distribution in a variety of cell types and its essential role in fluid and electrolyte transport in several epithelial tissues. We summarize this literature and speculate on the future characterization of this transport system. Although this review focuses on cotransport as it relates to absorptive and secretory processes in epithelia, important information concerning the pharmacology, stoichiometry, and regulation of Na-K-Cl cotransport in nonepithelial systems (i.e., erythrocytes, fibroblasts, squid axon, etc.) has been included to supplement areas that are less well established in the epithelial literature.


Asunto(s)
Proteínas Portadoras/metabolismo , Epitelio/metabolismo , Simportadores , Marcadores de Afinidad , Animales , Bumetanida/metabolismo , Proteínas Portadoras/antagonistas & inhibidores , Cationes/farmacología , Predicción , Cloruro de Potasio/metabolismo , Simportadores del Cloruro de Sodio , Simportadores de Cloruro de Sodio-Potasio , Tritio
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA